Test Bank for Pharmacology and the Nursing Process 10th Edition By
Linda Lilley, Shelly Collins, Julie Snyder Chapter 1-58 |Complete
Latest 2027
,TABLE OF CONTENTS
Chapter 1: The Nursing Process and Drug Therapy
Chapter 2: Pharmacologic Principles
Chapter 3: Lifespan Considerations
Chapter 4: Cultural, Legal, and Ethical Considerations
Chapter 5: Medication Errors: Preventing and Responding
Chapter 6: Patient Education and Drug Therapy
Chapter 7: Over-the-Counter Drugs and Herbal and Dietary Supplements
Chapter 8: Gene Therapy and Pharmacogenomics
Chapter 9: Photo Atlas of Drug Administration
Chapter 10: Analgesic Drugs
Chapter 11: General and Local Anesthetics
Chapter 12: Central Nervous System Depressants and Muscle Relaxants
Chapter 13: Central Nervous System Stimulants and Related Drugs
Chapter 14: Antiepileptic Drugs
Chapter 15: Antiparkinson Drugs
Chapter 16: Psychotherapeutic Drugs
Chapter 17: Substance Use Disorder
Chapter 18: Adrenergic Drugs
Chapter 19: Adrenergic-Blocking Drugs
Chapter 20: Cholinergic Drugs
Chapter 21: Cholinergic-Blocking Drugs
Chapter 22: Antihypertensive Drugs
Chapter 23: Antianginal Drugs
Chapter 24: Heart Failure Drugs
Chapter 25: Antidysrhythmic Drugs
Chapter 26: Coagulation Modifier Drugs
Chapter 27: Antilipemic Drugs
Chapter 28: Diuretic Drugs
,Chapter 29: Fluids and Electrolytes
Chapter 30: Pituitary Drugs
Chapter 31: Thyroid and Antithyroid Drugs
Chapter 32: Antidiabetic Drugs
Chapter 33: Adrenal Drugs
Chapter 34: Women’s Health Drugs
Chapter 35: Men’s Health Drugs
Chapter 36: Antihistamines, Decongestants, Antitussives, and Expectorants
Chapter 37: Respiratory Drugs
Chapter 38: Antibiotics Part 1
Chapter 39: Antibiotics Part 2
Chapter 40: Antiviral Drugs
Chapter 41: Antitubercular Drugs
Chapter 42: Antifungal Drugs
Chapter 43: Antimalarial, Antiprotozoal, and Anthelmintic Drugs
Chapter 44: Antiinflammatory and Antigout Drugs
Chapter 45: Antineoplastic Drugs Part 1: Cancer Overview and Cell Cycle–Specific Drugs
Chapter 46: Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific and Miscellaneous Drugs
Chapter 47: Biologic Response–Modifying and Antirheumatic Drugs
Chapter 48: Immunosuppressant Drugs
Chapter 49: Immunizing Drugs
Chapter 50: Acid-Controlling Drugs
Chapter 51: Bowel Disorder Drugs
Chapter 52: Antiemetic and Antinausea Drugs
Chapter 53: Vitamins and Minerals
Chapter 54: Anemia Drugs
Chapter 55: Nutritional Supplements
Chapter 56: Dermatologic Drugs
Chapter 57: Ophthalmic Drugs
, Chapter 58: Otic Drugs
CHAPTER 1: The Nursing Process and Drug Therapy
1. A nurse is caring for a patient receiving therapy related to assessment before therapy. Which
action is most appropriate?
A. Assess the patient and relevant baseline data before proceeding.
B. Ignore the assessment because the medication is already prescribed.
C. Administer an additional dose without reassessment.
D. Document the medication as effective before it is given.
Answer: A
Rationale: The priority is to assess the patient and relevant baseline information before or during
therapy related to assessment before therapy. Assessment establishes safety needs, identifies
contraindications or risks, and provides a comparison point for later evaluation. The other choices omit
essential nursing assessment or represent unsafe medication practice.
2. Which finding is most important for the nurse to recognize when caring for a patient receiving
therapy related to nursing diagnosis?
A. Assume every symptom is unrelated to therapy.
B. Stop all prescribed medications immediately.
C. Tell the patient that monitoring is unnecessary.
D. Monitor for the expected therapeutic response and important adverse effects.
Answer: D
Rationale: Nursing care for nursing diagnosis requires monitoring both therapeutic response and
clinically important adverse effects. A medication should not be assumed to be safe or effective simply
because it was prescribed. Ongoing assessment allows the nurse to recognize complications early and
communicate changes to the prescriber.
3. The nurse is providing discharge teaching about planning outcomes. Which patient statement
indicates correct understanding?
A. The patient will stop the drug whenever symptoms improve.
B. The patient believes adverse effects never need to be reported.
C. The patient correctly identifies the purpose, major precautions, and when to seek help.
D. The patient plans to double the dose if one dose is missed.
Linda Lilley, Shelly Collins, Julie Snyder Chapter 1-58 |Complete
Latest 2027
,TABLE OF CONTENTS
Chapter 1: The Nursing Process and Drug Therapy
Chapter 2: Pharmacologic Principles
Chapter 3: Lifespan Considerations
Chapter 4: Cultural, Legal, and Ethical Considerations
Chapter 5: Medication Errors: Preventing and Responding
Chapter 6: Patient Education and Drug Therapy
Chapter 7: Over-the-Counter Drugs and Herbal and Dietary Supplements
Chapter 8: Gene Therapy and Pharmacogenomics
Chapter 9: Photo Atlas of Drug Administration
Chapter 10: Analgesic Drugs
Chapter 11: General and Local Anesthetics
Chapter 12: Central Nervous System Depressants and Muscle Relaxants
Chapter 13: Central Nervous System Stimulants and Related Drugs
Chapter 14: Antiepileptic Drugs
Chapter 15: Antiparkinson Drugs
Chapter 16: Psychotherapeutic Drugs
Chapter 17: Substance Use Disorder
Chapter 18: Adrenergic Drugs
Chapter 19: Adrenergic-Blocking Drugs
Chapter 20: Cholinergic Drugs
Chapter 21: Cholinergic-Blocking Drugs
Chapter 22: Antihypertensive Drugs
Chapter 23: Antianginal Drugs
Chapter 24: Heart Failure Drugs
Chapter 25: Antidysrhythmic Drugs
Chapter 26: Coagulation Modifier Drugs
Chapter 27: Antilipemic Drugs
Chapter 28: Diuretic Drugs
,Chapter 29: Fluids and Electrolytes
Chapter 30: Pituitary Drugs
Chapter 31: Thyroid and Antithyroid Drugs
Chapter 32: Antidiabetic Drugs
Chapter 33: Adrenal Drugs
Chapter 34: Women’s Health Drugs
Chapter 35: Men’s Health Drugs
Chapter 36: Antihistamines, Decongestants, Antitussives, and Expectorants
Chapter 37: Respiratory Drugs
Chapter 38: Antibiotics Part 1
Chapter 39: Antibiotics Part 2
Chapter 40: Antiviral Drugs
Chapter 41: Antitubercular Drugs
Chapter 42: Antifungal Drugs
Chapter 43: Antimalarial, Antiprotozoal, and Anthelmintic Drugs
Chapter 44: Antiinflammatory and Antigout Drugs
Chapter 45: Antineoplastic Drugs Part 1: Cancer Overview and Cell Cycle–Specific Drugs
Chapter 46: Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific and Miscellaneous Drugs
Chapter 47: Biologic Response–Modifying and Antirheumatic Drugs
Chapter 48: Immunosuppressant Drugs
Chapter 49: Immunizing Drugs
Chapter 50: Acid-Controlling Drugs
Chapter 51: Bowel Disorder Drugs
Chapter 52: Antiemetic and Antinausea Drugs
Chapter 53: Vitamins and Minerals
Chapter 54: Anemia Drugs
Chapter 55: Nutritional Supplements
Chapter 56: Dermatologic Drugs
Chapter 57: Ophthalmic Drugs
, Chapter 58: Otic Drugs
CHAPTER 1: The Nursing Process and Drug Therapy
1. A nurse is caring for a patient receiving therapy related to assessment before therapy. Which
action is most appropriate?
A. Assess the patient and relevant baseline data before proceeding.
B. Ignore the assessment because the medication is already prescribed.
C. Administer an additional dose without reassessment.
D. Document the medication as effective before it is given.
Answer: A
Rationale: The priority is to assess the patient and relevant baseline information before or during
therapy related to assessment before therapy. Assessment establishes safety needs, identifies
contraindications or risks, and provides a comparison point for later evaluation. The other choices omit
essential nursing assessment or represent unsafe medication practice.
2. Which finding is most important for the nurse to recognize when caring for a patient receiving
therapy related to nursing diagnosis?
A. Assume every symptom is unrelated to therapy.
B. Stop all prescribed medications immediately.
C. Tell the patient that monitoring is unnecessary.
D. Monitor for the expected therapeutic response and important adverse effects.
Answer: D
Rationale: Nursing care for nursing diagnosis requires monitoring both therapeutic response and
clinically important adverse effects. A medication should not be assumed to be safe or effective simply
because it was prescribed. Ongoing assessment allows the nurse to recognize complications early and
communicate changes to the prescriber.
3. The nurse is providing discharge teaching about planning outcomes. Which patient statement
indicates correct understanding?
A. The patient will stop the drug whenever symptoms improve.
B. The patient believes adverse effects never need to be reported.
C. The patient correctly identifies the purpose, major precautions, and when to seek help.
D. The patient plans to double the dose if one dose is missed.
